期刊文献+

100例危重患者药学监护分析

Analysis of pharmaceutical care on 100 critical patients
下载PDF
导出
摘要 目的 通过临床药师对危重患者进行药学监护的总结、分析,探讨临床药师在危重患者治疗过程中的作用。方法 选取2012年1月~2013年4月宝鸡市人民医院各科室重症监护室入住超过24 h的100例危重患者进行登记,对患者的病情、药物的选择、治疗后的临床效果评价、患者用药教育、不良反应监测及干预措施等方面实施全程药学监护。结果 心脑血管、泌尿系统药物以及抗感染药物的用药频次高,并且存在部分药物无指征用药现象。结论 临床药师只有掌握了必需的医学、药学理论基础知识,在实践中建立一定的临床思维能力,强化药物应用的能力,才能提高药学服务质量,提高合理用药的水平。 Objective To discuss the role of clinical pharmacists in treatment process for critical patients by the sum- mary and analysis of pharmaceutical care on critical patients. Methods From January 2012 to April 2013, in Baoji People's Hospital, 100 critical patients in each clinical Intensive Care Unit more than 24 h were registered, and they were given whole course pharmaceutical care on symptoms, selection of drugs, the clinical efficacy of evaluation after treatment, adverse reaction monitoring, education, intervention measures and so on. Results The frequencies of drugs for cardiovascular system, urinary system, anti-infection were high, and there were non-rational use of drugs appearance. Conclusion Clinical pharmacists only master the necessary theoretical knowledge of medicine and pharmacy, they will establish certain clinical thinking ability in practice, strengthen the drug application ability, which can improve the quality of pharmaceutical care and the level of rational drug use.
出处 《中国医药导报》 CAS 2015年第21期150-152,156,共4页 China Medical Herald
基金 陕西省宝鸡市卫生局科研立项课题(2013-31)
关键词 临床药师 危重患者 药学监护 药学干预 Clinical pharmacists Critical patients Pharmaceutical care Pharmaceutical intervention
  • 相关文献

参考文献20

  • 1Surur AS,Teni FS, Girmay G,et al. Assessment of the structural and process aspects of pharmaceutical care at a university hospital in Ethiopia [J]. J Pharm Bioallied Sci, 2015,7(2) :97-102.
  • 2高秀丽.临床药师参与药学监护工作体会[J].临床合理用药杂志,2014,7(35):179-180. 被引量:1
  • 3Dabiri Y, Fahimi F, Jamaati H, et al. The comparison of extemporaneous preparations of omeprazole,pantoprazole oral suspension and intravenous pantoprazole on the gas- trie pH of critically ill-patients [J]. Indian J Crit Care Med, 2015,19(1) :21-26.
  • 4Baysal B,Entrk H, Masri O,et al. Effect of pantoprazole and Helicobacter pylori therapy on uninvestigated dyspep- tic patients [J]. Turk J Gastroenterol, 2015,26(1) : 6-14.
  • 5Yao DK,Chen H, Wang L, et al. Comparison of intra- venous plus oral pantoprazole therapy and oral pantopra- zole alone for preventing gastrointestinal bleeding in acute coronary syndrome patients with high bleeding risk [J]. Heart Lung Circ, 2015,14(15) : 122-125.
  • 6Ramos-Martfn V,Paulus S, Siner S, et al. Population pharmacokinetics of teicoplanin in children [J]. Antimi- crob Agents Chemother, 2014,58( 11 ) : 6920-6927.
  • 7Sato Y,Tokimatsu I, Suzuki Y,et al. Significance of high trough concentration of teicoplanin in the treatment of me- thicillin-resistant staphylococcus aureus infection [J]. Che- motherapy, 2015,60(4) : 274-278.
  • 8Kim SW. Is therapeutic drug monitoring of teicoplanin useful? [J]. Infect Chemother, 2014,46(1) : 64-65.
  • 9Chawla M,Malve H,Shah H,et al. Safety of intravenous insulin aspart compared to regular human insulin in pa- tients undergoing ICU monitoring post cardiac surgery:an Indian experience [J]. J Diabetes Metab Disord,2015,3 14) : 20-29.
  • 10Yang W,Zhuang X,Li Y,et al. Improvements in quality of life associated with biphasic insulin aspart 30 in type 2 diabetes patients in China: results from the Alchieve observational study [J]. Health Qual Life Outcomes , 2014, 26(12) : 137-145.

二级参考文献70

共引文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部